5 Stocks Dragging The Health Services Industry Downward

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 205 points (-1.3%) at 15,494 as of Monday, Feb. 3, 2014, 11:55 AM ET. The NYSE advances/declines ratio sits at 659 issues advancing vs. 2,313 declining with 134 unchanged.

The Health Services industry currently sits down 1.4% versus the S&P 500, which is down 1.3%. On the negative front, top decliners within the industry include Align Technology ( ALGN), down 5.7%, Cooper Companies ( COO), down 3.3%, Universal Health Services ( UHS), down 2.9%, Edwards Life ( EW), down 2.5% and Mettler-Toledo International ( MTD), down 2.5%.

TheStreet would like to highlight 5 stocks pushing the industry lower today:

5. Agilent Technologies ( A) is one of the companies pushing the Health Services industry lower today. As of noon trading, Agilent Technologies is down $0.91 (-1.6%) to $57.24 on light volume. Thus far, 667,673 shares of Agilent Technologies exchanged hands as compared to its average daily volume of 2.4 million shares. The stock has ranged in price between $57.14-$58.48 after having opened the day at $58.15 as compared to the previous trading day's close of $58.15.

Agilent Technologies, Inc. provides bio-analytical and electronic measurement solutions and services to the life sciences, chemical analysis, diagnostics and genomics, communications, and electronics industries worldwide. Agilent Technologies has a market cap of $19.7 billion and is part of the health care sector. The company has a P/E ratio of 28.3, above the S&P 500 P/E ratio of 17.7. Shares are up 1.7% year-to-date as of the close of trading on Friday. Currently there are 12 analysts that rate Agilent Technologies a buy, no analysts rate it a sell, and 1 rates it a hold.

TheStreet Ratings rates Agilent Technologies as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Agilent Technologies Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

4. As of noon trading, St Jude Medical ( STJ) is down $0.84 (-1.4%) to $59.89 on light volume. Thus far, 669,945 shares of St Jude Medical exchanged hands as compared to its average daily volume of 2.4 million shares. The stock has ranged in price between $59.84-$60.58 after having opened the day at $60.57 as compared to the previous trading day's close of $60.73.

St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. It operates in two divisions, Cardiovascular and Ablation Technologies, and Implantable Electronic Systems. St Jude Medical has a market cap of $17.9 billion and is part of the health care sector. The company has a P/E ratio of 16.3, below the S&P 500 P/E ratio of 17.7. Shares are down 2.0% year-to-date as of the close of trading on Friday. Currently there are 11 analysts that rate St Jude Medical a buy, 1 analyst rates it a sell, and 10 rate it a hold.

TheStreet Ratings rates St Jude Medical as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, increase in net income, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full St Jude Medical Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

3. As of noon trading, Covidien ( COV) is down $1.06 (-1.6%) to $67.18 on average volume. Thus far, 1.0 million shares of Covidien exchanged hands as compared to its average daily volume of 2.1 million shares. The stock has ranged in price between $67.16-$68.40 after having opened the day at $68.32 as compared to the previous trading day's close of $68.24.

Covidien plc develops, manufactures, and sells healthcare products for use in clinical and home settings worldwide. Covidien has a market cap of $30.9 billion and is part of the health care sector. The company has a P/E ratio of 20.0, above the S&P 500 P/E ratio of 17.7. Shares are up 0.7% year-to-date as of the close of trading on Friday. Currently there are 14 analysts that rate Covidien a buy, no analysts rate it a sell, and 2 rate it a hold.

TheStreet Ratings rates Covidien as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, increase in stock price during the past year and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Covidien Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, HCA Holdings ( HCA) is down $0.66 (-1.3%) to $49.61 on average volume. Thus far, 1.2 million shares of HCA Holdings exchanged hands as compared to its average daily volume of 2.9 million shares. The stock has ranged in price between $49.58-$50.45 after having opened the day at $50.27 as compared to the previous trading day's close of $50.27.

HCA Holdings, Inc., through its subsidiaries, provides health care services. HCA Holdings has a market cap of $22.2 billion and is part of the health care sector. The company has a P/E ratio of 15.9, below the S&P 500 P/E ratio of 17.7. Shares are up 5.4% year-to-date as of the close of trading on Friday. Currently there are 15 analysts that rate HCA Holdings a buy, no analysts rate it a sell, and 2 rate it a hold.

TheStreet Ratings rates HCA Holdings as a sell. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share and poor profit margins. Get the full HCA Holdings Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, Thermo Fisher Scientific ( TMO) is down $0.77 (-0.7%) to $114.37 on average volume. Thus far, 1.1 million shares of Thermo Fisher Scientific exchanged hands as compared to its average daily volume of 1.8 million shares. The stock has ranged in price between $114.26-$115.87 after having opened the day at $115.17 as compared to the previous trading day's close of $115.14.

Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacture, analysis, discovery, and diagnostics. Thermo Fisher Scientific has a market cap of $41.6 billion and is part of the health care sector. The company has a P/E ratio of 32.9, above the S&P 500 P/E ratio of 17.7. Shares are up 3.4% year-to-date as of the close of trading on Friday. Currently there are 12 analysts that rate Thermo Fisher Scientific a buy, no analysts rate it a sell, and none rate it a hold.

TheStreet Ratings rates Thermo Fisher Scientific as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth, reasonable valuation levels, good cash flow from operations and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Thermo Fisher Scientific Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

Ackman Investment Buoys Lowe's; DraftKings Responds to FanDuel Merger -- ICYMI

Ackman Investment Buoys Lowe's; DraftKings Responds to FanDuel Merger -- ICYMI

Replay: Jim Cramer on the Markets, Tiffany, Micron Technology and Union Pacific

Replay: Jim Cramer on the Markets, Tiffany, Micron Technology and Union Pacific

Carnival CEO Arnold Donald: China Will Become the Largest Cruise Market

Carnival CEO Arnold Donald: China Will Become the Largest Cruise Market

Red Robin Slumps After Earnings Miss

Red Robin Slumps After Earnings Miss

Owner of Moviepass Sees Stock Plummet

Owner of Moviepass Sees Stock Plummet